CardieX Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
34
- Stock Symbol
-
CDX
- Investments
-
3
- Share Price
-
$0.09
- (As of Tuesday Closing)
CardieX General Information
Description
CardieX Ltd is a health technology company, developing solutions for health disorders. The AtCor Medical division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its patented SphygmoCor technology. It also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. It reports in a single segment being sales of cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia and Australia/New Zealand.
Contact Information
Website
www.cardiex.comCorporate Office
- 55 Lime Street, Barangaroo
- Suite 301
- Sydney, New South Wales 2000
- Australia
Corporate Office
- 55 Lime Street, Barangaroo
- Suite 301
- Sydney, New South Wales 2000
- Australia
CardieX Timeline
CardieX Stock Performance
As of 12-Nov-2024, CardieX’s stock price is $0.09. Its current market cap is $27.1M with 294M shares.
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.09 | $0.07 | $0.03 - $0.10 | $27.1M | 294M | 343K |
CardieX Financials Summary
As of 30-Sep-2024, CardieX has a trailing 12-month revenue of null.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
---|---|---|---|---|
EV | 11,012 | 13,192 | 13,405 | 23,916 |
Revenue | 7,147 | 3,095 | 2,947 | |
EBITDA | (3,687) | (12,454) | (8,548) | |
Net Income | (4,434) | (12,697) | (8,558) | |
Total Assets | 8,455 | 9,622 | 8,515 | |
Total Debt | 2,582 | 2,839 | 1,470 |
CardieX Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
CardieX Comparisons
Industry
Financing
Details
CardieX Competitors (3)
One of CardieX’s 3 competitors is Compumedics, a Corporation company based in Melbourne, Australia.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Compumedics | Corporation | Melbourne, Australia | ||||
Atomo Diagnostics | Formerly VC-backed | Leichhardt, Australia | ||||
Austco Healthcare | Corporation | Melbourne, Australia |
CardieX Signals
CardieX Investments & Acquisitions (3)
CardieX’s most recent deal was a Merger/Acquisition with Blumio. The deal was made on 15-Nov-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Blumio | 15-Nov-2022 | Merger/Acquisition | Monitoring Equipment | ||
InHealth Lifestyle Therapeutics | 30-Jun-2019 | Seed Round | Clinics/Outpatient Services | ||
Blumio | 01-Nov-2018 | Early Stage VC | Monitoring Equipment |
CardieX Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
InHealth Lifestyle Therapeutics | Clinics/Outpatient Services | Los Angeles, CA |
CardieX FAQs
-
When was CardieX founded?
CardieX was founded in 2005.
-
Where is CardieX headquartered?
CardieX is headquartered in Sydney, Australia.
-
What is the size of CardieX?
CardieX has 34 total employees.
-
What industry is CardieX in?
CardieX’s primary industry is Diagnostic Equipment.
-
Is CardieX a private or public company?
CardieX is a Public company.
-
What is CardieX’s stock symbol?
The ticker symbol for CardieX is CDX.
-
What is the current stock price of CardieX?
As of 12-Nov-2024 the stock price of CardieX is $0.09.
-
What is the current market cap of CardieX?
The current market capitalization of CardieX is $27.1M.
-
Who are CardieX’s competitors?
Compumedics, Atomo Diagnostics, and Austco Healthcare are competitors of CardieX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »